Implant Sciences starts radioactive stent trial
This article was originally published in Clinica
Executive Summary
Implant Sciences has begun a pre-clinical study in animals to assess its radioactive coronary stents for preventing restenosis. The company's multiple isotope-based stents, which contain phosphorous-32 on the stent body with a spike of palladium-103 activity at each end, could help address the well-documented problem seen with competing products - edge-stent restenosis.